Cart
sales@molnova.com
N-desmethyl Enzalutamide
CAS No. 1242137-16-1
N-desmethyl Enzalutamide( N-desmethyl MDV3100 | N-desmethyl MDV 3100 | N-desmethyl MDV-3100 )
Catalog No. M10977 CAS No. 1242137-16-1
Amajor metabolite of Enzalutamide (MDV3100) which is an androgen-receptor (AR) antagonist for treatment of prostate cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | Get Quote |
|
| 5MG | 72 | Get Quote |
|
| 10MG | 102 | Get Quote |
|
| 25MG | 210 | Get Quote |
|
| 50MG | 404 | Get Quote |
|
| 100MG | 593 | Get Quote |
|
| 500MG | 1251 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameN-desmethyl Enzalutamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionAmajor metabolite of Enzalutamide (MDV3100) which is an androgen-receptor (AR) antagonist for treatment of prostate cancer.
-
DescriptionAmajor metabolite of Enzalutamide (MDV3100) which is an androgen-receptor (AR) antagonist for treatment of prostate cancer.
-
In Vitro——
-
In Vivo——
-
SynonymsN-desmethyl MDV3100 | N-desmethyl MDV 3100 | N-desmethyl MDV-3100
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorAndrogen Receptor (AR)
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1242137-16-1
-
Formula Weight450.4094
-
Molecular FormulaC20H14F4N4O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 48 mg/mL
-
SMILESCC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)N)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C
-
Chemical NameBenzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tran C, et al. Science. 2009 May 8;324(5928):787-90.
2. Richards J, et al. Cancer Res. 2012 May 1;72(9):2176-82.
3. Gibbons JA, et al. Clin Pharmacokinet. 2015 Oct;54(10):1043-55.
molnova catalog
related products
-
Zanoterone
Zanoterone is an AR antagonist (androgen receptor).Zanoterone has antitumor activity for the treatment of genitourinary disorders and oncological disorders and may be used in the study of prostate cancer.
-
ACP-105
ACP-105 is a novel and potent nonsteroidal selective androgen receptor modulator (SARM) with partial agonist activity relative to the natural androgen testosterone.
-
RU 58841
A nonsteroidal, specific androgen receptor inhibitor; be useful for the topical treatment of androgen-dependent skin disorders such as acne, androgenetic alopecia and hirsutism.
